Sekar Kathiresan's Net Worth
$16.6 Million
Who is Sekar Kathiresan?
Sekar Kathiresan has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include Verve Therapeutics, Inc., and Relay Therapeutics, Inc..
SEC CIK
Sekar Kathiresan's CIK is 0001864112
Past Insider Trading and Trends
2022 was Sekar Kathiresan's most active year for acquiring shares with 10 total transactions. Sekar Kathiresan's most active month to acquire stocks was the month of June. 2022 was Sekar Kathiresan's most active year for disposing of shares, totalling 14 transactions. Sekar Kathiresan's most active month to dispose stocks was the month of November. 2022 saw Sekar Kathiresan paying a total of $411,063.68 for 1,085,425 shares, this is the most they've acquired in one year. In 2021 Sekar Kathiresan cashed out on 325,386 shares for a total of $6,436,138.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.955
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.34% | 30K |
$2.87 | $86,100.00 | 351.13K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
$17.52 | -$1,613,122.14 | 317.84K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$15.65 | -$1,425,500.00 | 317.84K |
Scheduled
|
Aug 10
| ||
Form 4
|
—
|
0
|
$15.65 | -$1,425,500.00 | 317.84K |
Scheduled
|
Jul 19
| ||
Form 4
|
—
|
0
|
—
|
—
| 558.84K |
Jul 7 - Jul 12
| |||
Form 4
| +17.08% | 69.67K |
$2.87 | $199,964.38 | 477.52K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
$20.65 | -$72,013.70 | 406.54K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$20.78 | -$1,887,851.21 | 406.54K |
Scheduled
|
Dec 27 - Dec 28
| ||
Form 4
|
—
|
0
|
$20.35 | -$4,322,143.83 | 406.54K |
Scheduled
|
Dec 22 - Dec 23
| ||
Form 4
| +0.62% | 2.5K |
$19.00 | $47,500.00 | 406.54K |
Jun 17 - Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relay Therapeutics, Inc. (RLAY) Snapshot price: $8.771
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||